Hemochromatosis gene mutations may affect the survival of patients with myelodysplastic syndrome-Reference-Cited by-同舟云学术

Hemochromatosis gene mutations may affect the survival of patients with myelodysplastic syndrome

Published:2016-03-15 Issue:3 Volume:21 Page:170-174
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Lucijanić Marko¹,Pejša Vlatko¹²,Mitrović Zdravko¹,Štoos-Veić Tajana³⁴,Livun Ana⁵,Jakšić Ozren¹²,Vasilj Tamara¹,Piršić Mario¹,Hariš Višnja¹,Prka Željko¹,Kušec Rajko¹²⁴

Affiliation:

1. Department of Hematology, University Hospital Dubrava, Zagreb, Croatia

2. University of Zagreb, School of Medicine, Zagreb, Croatia

3. Department of Clinical Cytology and Cytometry, University Hospital Dubrava, Zagreb, Croatia

4. University of Osijek, School of Medicine, Croatia

5. Clinical Institute of Laboratory Diagnosis, Division of Molecular Diagnosis and Genetics, University Hospital Dubrava, Zagreb, Croatia

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10245332.2015.1101964

Reference23 articles.

1. Iron overload in MDS—pathophysiology, diagnosis, and complications

2. Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromes

3. Improved survival in MDS patients receiving iron chelation therapy – A matched pair analysis of 188 patients from the Düsseldorf MDS registry

4. Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes

5. Comparison of 24-month outcomes in chelated and non-chelated lower-risk patients with myelodysplastic syndromes in a prospective registry

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and treatment of anemia and secondary iron overload in patients with a myelodysplastic syndrome: Real-world data from a multicenter cohort study;Transfusion Clinique et Biologique;2023-08

2. A Systematic Literature Review of the Relationship between Serum Ferritin and Outcomes in Myelodysplastic Syndromes;Journal of Clinical Medicine;2022-02-08

3. A Review of Iron Overload in Beta-Thalassemia Major, and a Discussion on Alternative Potent Iron Chelation Targets;Plasmatology;2022-01

4. Could haemochromatosis ( HFE ) gene mutations affect response to iron chelation in myelodysplastic syndrome?;British Journal of Haematology;2019-05

5. Late-onset Hemochromatosis: Co-inheritance of β-thalassemia and Hereditary Hemochromatosis in a Chinese Family: A Case Report and Epidemiological Analysis of Diverse Populations;Internal Medicine;2018-12-01